Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro

@article{Dufes2003EffectsOT,
  title={Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro},
  author={Christine Dufes and C{\'e}line Alleaume and Alicia Montoni and Jean-Christophe Olivier and Jean-Marc Muller},
  journal={Journal of Molecular Neuroscience},
  year={2003},
  volume={21},
  pages={91-102}
}
The growth rate of numerous cancer cell lines is regulated in part by actions of neuropeptides of the vasoactive intestinal peptide (VIP) family, which also includes pituitary adenylate cyclase-activating peptide (PACAP), glucagon, and peptide histidine/isoleucine (PHI). The aim of this work was to investigate the effect of these peptides on the growth of the rat glioblastoma cell line C6 in vitro. We also sought to determine which binding sites were correlated with the effects observed… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Effects of PACAP and VIP on cAMP-generating System and Proliferation of C6 Glioma Cells

  • Journal of Molecular Neuroscience
  • 2008
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples

Andrea Tamás, Andras Javorhazy, +7 authors Zalan Szanto
  • Journal of Molecular Neuroscience
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND

Antiproliferative Effects of PACAP and VIP in Serum-Starved Glioma Cells

  • Journal of Molecular Neuroscience
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 47 REFERENCES

Avasoactive intestinal polypeptide antagonist unhibits the growth of glioblastoma cells

A. Sharma, J. Walters, +4 authors T W.Moody
  • J. Mol. Neurosci
  • 2001
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

  • The Journal of pharmacology and experimental therapeutics
  • 1991
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL